INTEL CORP ⋅ 10-Q ⋅ 7/24 Philip Morris International Inc. ⋅ 10-Q ⋅ 7/24 TEXAS INSTRUMENTS INC ⋅ 10-Q ⋅ 7/24 AMERICAN EXPRESS CO ⋅ 10-Q ⋅ 7/24 NEXTERA ENERGY INC ⋅ 10-Q ⋅ 7/24 CME GROUP INC. ⋅ 10-Q ⋅ 7/24 KINDER MORGAN, INC. ⋅ 10-Q ⋅ 7/24 TE Connectivity plc ⋅ 10-Q ⋅ 7/24 LAS VEGAS SANDS CORP ⋅ 10-Q ⋅ 7/24 HALLIBURTON CO ⋅ 10-Q ⋅ 7/24

INTEL CORP ⋅ 10-Q ⋅ 7/24 Philip Morris International Inc. ⋅ 10-Q ⋅ 7/24 TEXAS INSTRUMENTS INC ⋅ 10-Q ⋅ 7/24 AMERICAN EXPRESS CO ⋅ 10-Q ⋅ 7/24 NEXTERA ENERGY INC ⋅ 10-Q ⋅ 7/24 CME GROUP INC. ⋅ 10-Q ⋅ 7/24 KINDER MORGAN, INC. ⋅ 10-Q ⋅ 7/24 TE Connectivity plc ⋅ 10-Q ⋅ 7/24 LAS VEGAS SANDS CORP ⋅ 10-Q ⋅ 7/24 HALLIBURTON CO ⋅ 10-Q ⋅ 7/24

VERTEX PHARMACEUTICALS INC / MA

Pharmaceutical Preparations | SIC: 2834
Phone: 6173416393

CIK: 0000875320
EIN: 043039129
State Location: MA
State of Inc.: MA

Nasdaq:VRTX

Form: 4

Filing Date: 23 Jul 2026
Report Date: 21 Jul 2026
Accepted: 23 Jul 2026 02:13 p.m.
Accession Number: 0000875320-26-000251

Act: None
File Number: None
Film Number: None

Documents

Primary Document: FORM 4

Accepted: 23 Jul 2026 02:13 p.m.

0000875320-26-000251-index-headers.html

Last Modified: 23 Jul 2026 02:13 p.m.

0000875320-26-000251-index.html

Last Modified: 23 Jul 2026 02:13 p.m.

0000875320-26-000251.txt

Last Modified: 23 Jul 2026 02:13 p.m.

wk-form4_1784837586.xml

Last Modified: 23 Jul 2026 02:13 p.m.